In 2025, the global licorice extract sector was valued at USD 0.9 billion, and with consistent increase in sales, the industry size is projected to cross USD 1.0 billion in 2026 at a CAGR of 6.2% during the forecast period. Surge in purchase based on concentration takes total market valuation to USD 1.7 billion through 2036 as manufacturers move away from bulk licorice root buying and toward standardized extract grades that are easier to qualify across finished-product programs.

Buyers now spend less time asking if licorice belongs in a formula and more time choosing an extract grade that moves through development with fewer setbacks. Market change has shifted the category from a raw botanical trade into a specification led business. Extracts and herbal nutraceuticals are judged by assay control and by consistency and by finished product fit. Higher concentration does not always solve commercial problems. Mid-range grades often move faster because they provide enough active strength without pushing cost or handling or formulation limits too far. Demand grows when extract grades can support food and wellness and care applications without forcing separate buying logic for each use case.
Standardized documentation acts as the gate that turns interest into repeat buying. Suppliers who can deliver the same extract band with stable handling characteristics make formulation work easier and allow more finished product programs to move ahead. Quality records and clear specifications help teams predict performance and reduce trial and error during development. Manufacturers gain confidence when handling stays consistent and when assay results match expectations across batches. Repeatability matters even in botanical CO2 extracts and other high processing niches because consistent results carry more weight than novelty in commercial decisions. Buyers reward suppliers who prove stability with ongoing orders and with broader application use.
Australia is expected to advance at 12.3%, India at 7.4%, and China at 7.1% as botanical ingredient use widens across wellness and therapeutic applications. Industry demand in the USA is likely to rise at a projected 5.8%, while Germany seemingly follows at an estimate 5.3%, the U.K. at 5.1%, and Japan at 4.7% as mature formulation systems keep demand steady rather than fast. Rapidly expanding countries still benefit from capacity build-out with established ones relying more on documentation quality and application depth, with stable repeat demand.

Powder (solid extract) matters because it is easier to move or store, and blend without adding extra handling steps. Bulk users do not need a complicated delivery format when dry formats or the medicinal form and premix work can be built around a stable powder base. In 2026, powder (solid extract) is projected to secure an estimate 33.5% of total product type share as blocks and paste still carry weight where flavor delivery and familiar processing matter and as aqueous formats suit liquid systems that need faster dispersion. Manufacturers usually prefer the format that reduces handling loss and keeps batch work simple, explaining why product form is a practical decision rather than a branding choice. Product mix within root share analysis points to a plain reality being easier plant handling often beats wider format variety when repeat manufacturing matters more than novelty.

Nutraceutical & Dietary Supplements sit at the center of demand because these products depend on repeatable ingredient behavior more than occasional flavor use, and thereby is expected to garner a projected 43.9% in 2026. A finished formula has less room for active variability when capsules, powders, tablets, and wellness blends need the same input each time. Confectionery follows closely because licorice still carries familiar flavor value, while respiratory formulations and cosmetics use the ingredient for a different reason tied to functional positioning. Demand across herbal medicines also supports this structure because standardized extract grades can move more easily between supplement and therapeutic-adjacent formats than bulk root material. Application leadership comes from repeatable use conditions, not from the widest consumer visibility.

Active compound profile decides how easy an extract is to position across different finished products. Very low concentrations can limit functional pull, and high concentrations can narrow the range of commercially comfortable uses. Low Glycyrrhizin stays relevant where milder positioning or handling is preferred. High and Ultra-High grades still matter when stronger active loading is needed, yet those grades are less universal. Buyers looking at botanical bioactives usually place more value on usable balance than on concentration headlines alone, leading the middle band to stay structurally important in this category. Medium glycyrrhizin is estimated to account for 28.6% share in 2026, and that leadership makes sense because it gives a workable middle ground between potency, yield, and formulation ease.

Standardized extract demand supports the category because manufacturers across food, wellness, and care applications need fewer surprises at the formulation stage. Raw botanical familiarity still matters. As repeat buying now depends more on assay clarity, concentration control, and easier batch matching. Transitions like this helps extract grades that can move across several end uses without major rework. Broader application width also improves stability because weakness in one use area does not automatically slow the full category.
Raw-material variation and glycyrrhizin sensitivity still limit how fast the category can widen. A manufacturer may like the ingredient profile, but approval slows when documentation is weak or the extract behaves differently from batch to batch. Finished-product teams also stay careful with concentration choice because stronger active loading can narrow the comfortable use range. Growth therefore depends on consistency as much as interest.
Regional performance does not move in one line. Faster-growth countries benefit from newer capacity build-out or wider botanical use, while mature ones depend more on stable formulation demand and stricter documentation.
.webp)
| Country | CAGR (2026-2036) |
|---|---|
| Australia | 12.3% |
| India | 7.4% |
| China | 7.1% |
| USA | 5.8% |
| Germany | 5.3% |
| UK | 5.1% |
| Japan | 4.7% |
Source: Future Market Insights (FMI) analysis, based on proprietary forecasting model and primary research


North America keeps demand grounded in established supplement and therapeutic use rather than rapid first-time expansion. Ingredient qualification carries weight here, so repeatable documentation and finished-product consistency matter from the start. Buyers do not need the widest format set if the selected grade can move through development with less rework. Growth in this region therefore comes from deeper specification use, not from casual adoption.
FMI observes, North America does not need the fastest growth rate to remain influential. Stable demand from qualified uses can matter more than headline speed, especially when USA licorice root sourcing logic and extract qualification need to stay aligned across several finished-product categories.
Europe leans toward documented quality, mature formulation routines, and narrower tolerance for raw-material inconsistency. Buyers in this region generally want cleaner paperwork and clearer concentration language before they widen usage. Favoring suppliers with steady grade control more than suppliers offering the broadest catalog. Regional demand therefore stays commercially solid even when expansion is moderate.
FMI analyses, Europe projects moderate growth can still produce dependable business. Clean specification language with stable application habits, and lower tolerance for inconsistency keep the region important for suppliers that want longer-running repeat demand rather than short bursts of opportunistic volume.
Asia Pacific carries the widest range of demand conditions in this study. Some countries benefit from deeper extraction and processing capacity, while others grow through expanding wellness use or broader acceptance of botanical ingredients in finished products. A mix of this sort creates stronger upside than in mature regions. It also produces more variation in how suppliers build their position. Regional growth improves when processing depth and end-use fit move together.
FMI assesses, Asia Pacific combines higher-growth conditions with more varied operating realities. Wider botanical familiarity helps, yet long-term positions still become stronger when extract quality, application fit, and processing discipline move in the same direction, a point that also appears in broader ASEAN licorice root demand patterns.

Mafco Worldwide LLC, Norevo GmbH, and Maruzen Pharmaceuticals Co., Ltd. sit in the part of the trade where standardized grades and cleaner documentation support repeat buying. F&C Licorice Ltd. and Zagros Licorice Co. remain important because long-running extract experience still matters when buyers want dependable form and concentration choices. Sepidan Osareh Jonoob Co., ASEH Licorice, and VPL Chemicals add depth to the field by serving different application needs and supply positions.
Givaudan (Naturex), Magnasweet, Ransom Naturals, and Sanat Products Ltd. show that the category extends beyond one narrow buying route. Some names matter more in flavor and mouthfeel use, while others matter in active positioning or personal care. Gansu Fanzhi Pharmaceutical, Qinghai Blicsweet Licorice Technology, and Xinjiang Long Hui Yuan Pharmaceutical add regional strength where root access and extract preparation sit closer together. Competition therefore stays moderately fragmented rather than tightly concentrated.
Buyers compare suppliers on consistency first, then on concentration control, application fit, and the ease of repeat qualification. One company may suit confectionery better, while another fits supplement or care use more naturally. Commercial positions hold up best when extract grades are simple to understand and easy to repeat across multiple finished-product programs.
Recent Developments

| Items | Values |
|---|---|
| Quantitative Units (2026) | USD 0.9 billion |
| Forecast Value (2036) | USD 1.7 billion |
| CAGR (2026 to 2036) | 6.2% |
| Product Type | Blocks (Solid Extract), Paste (Solid Extract), Powder (Solid Extract), Granules (Solid Extract), Aqueous Extract (Liquid), Hydroalcoholic Extract (Liquid), Oil-Soluble Extract (Liquid), Concentrated Liquid Extract, Standardized Glycyrrhizin Extract, Highly Purified Derivatives |
| Active Compound Profile | Low Glycyrrhizin (Below 10%), Medium Glycyrrhizin (10 to 30%), High Glycyrrhizin (30 to 60%), Ultra-High Glycyrrhizin (Above 60%), Deglycyrrhizinated Extract, Flavonoid or Glabridin-Enriched Extract |
| Application | Confectionery, Bakery, Dairy, Beverages (Functional, RTD, Herbal), Savory and Seasonings, Tobacco Flavoring, Respiratory Formulations, Gastrointestinal Treatments, Nutraceutical and Dietary Supplements, Traditional Medicine Systems, Cosmetics and Personal Care, Animal Feed and Veterinary |
| Extraction Method | Water Extraction, Ethanol Extraction, Hydroalcoholic Extraction, Solvent Extraction, Supercritical Extraction, Spray Drying, Vacuum Concentration |
| End User | Food and Beverage Manufacturers, Pharmaceutical Companies, Nutraceutical Brands, Cosmetic Manufacturers, Tobacco Companies, Contract Manufacturers, Herbal Formulators |
| Nature | Organic, Conventional |
| Distribution Channel | Direct Sales, Ingredient Distributors, Online B2B Platforms, Specialty Herbal Ingredient Suppliers |
| Regions Covered | North America, Europe, East Asia, South Asia, Middle East and Africa |
| Countries Covered | USA, China, India, Germany, Japan, UK |
| Key Companies Profiled | Mafco Worldwide LLC, Norevo GmbH, Maruzen Pharmaceuticals Co., Ltd., F&C Licorice Ltd., Zagros Licorice Co., Sepidan Osareh Co., ASEH Licorice, VPL Chemicals, Givaudan (Naturex), Magnasweet, Ransom Naturals, Sanat Products Ltd., Gansu Fanzhi Pharmaceutical, Qinghai Blicsweet Licorice Technology, Others |
| Additional Attributes | Revenue analysis by product type and active compound profile, concentration band penetration assessment, country-level demand modeling, extraction method cost benchmarking, derivative portfolio analysis, compliance-driven purchase evaluation, pricing structure benchmarking, and competitive landscape concentration assessment |
Source: Future Market Insights (FMI) analysis, based on proprietary forecasting model and primary research
This bibliography is provided for reader reference. The full FMI report contains the complete reference list with primary source documentation.
What was the industry value in 2025?
The global licorice extract sector secured USD 0.9 billion in 2025.
What size is expected in 2026?
Market value is expected to surpass USD 1.0 billion in 2026.
What value is projected for the market by 2036?
The global licorice extract industry is projected to reach USD 1.7 billion by 2036.
What CAGR is forecast from 2026 to 2036?
The industry is forecast to expand at a CAGR of 6.2% from 2026 to 2036.
Which product type leads demand?
Powder (solid extract) is expected to lead product type demand with a projected 33.5% share in 2026.
Which application segment ranks first?
Nutraceutical & dietary supplements are set to lead application demand with an estimated 43.9% share in 2026.
Which active compound profile leads the category?
Medium Glycyrrhizin is expected to lead the active compound profile segment with a projected 28.6% share in 2026.
Why does powder remain important?
Powder is poised to remain important because it is easier to store, transport, and dose in dry formulation systems.
Why do nutraceutical applications lead demand?
Nutraceutical use is likely to lead because repeatable active input matters more in supplement formats than occasional flavor use.
Why does Medium Glycyrrhizin lead?
Medium Glycyrrhizin is expected to lead because it balances usable potency with broader formulation range and easier commercial fit.
Which country is growing the fastest?
Australia is the fastest-growing country in this comparison with a forecast CAGR of 12.3%.
How fast is India expected to grow?
India is expected to advance at a CAGR of 7.4% by 2036.
How fast is China expected to grow?
China is projected to develop at a CAGR of 7.1% by 2036.
How fast is the U.S. expected to grow?
Demand in the U.S. is expected to rise at a CAGR of 5.8% by 2036.
How fast is Germany expected to grow?
Germany is likely to post an estimated CAGR of 5.3% during the forecast period.
How fast is the U.K. expected to grow?
The U.K. is expected to progress at a CAGR of 5.1% by 2036.
How fast is Japan expected to grow?
Japan is projected to expand at an estimated CAGR of 4.7% by 2036.
What is the main growth driver?
A shift toward standardized extract buying supports growth because manufacturers want clearer assay control and repeatable formulation performance.
What is the main restraint?
Raw-material variation and glycyrrhizin sensitivity remain the main restraints because they slow qualification and narrow comfortable use ranges.
What kind of competitive structure shapes the category?
Category remains moderately fragmented, with global specialists and regional processors active across different grades and applications.
What is included in the study scope?
Scope covers standardized licorice extract formats and active compound profiles used in food, respiratory, supplement, and cosmetic applications.
What is excluded from the study scope?
Raw licorice root, unrelated botanical ingredients, and products outside standardized extract use are excluded from this study.
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.